Title: STARDUST – Holistic and integrated urban model for smart cities
Country: Europe wide.
Client: European Commision H2020 programme.
Alliance partner involved: Signosis, Belgium. Signosis is consortium member.
Description:The TRUST project, “Creating and enhancing trustworthy, responsible and equitable partnerships in international research” is funded under Horizon2020 and it will begin work in October 2015. The mission of the three years project is to counteract the practice of “Ethics dumping” or the application of double standards in research, by building international governance structures with new exciting network opportunities between Europe, India, Sub-Saharan Africa, China and Russia. In an interdisciplinary collaboration between multi-level ethics bodies, policy advisors, civil society organisations, funding organisations, industry and academic scholars the project will deliver three sets of tools based on participatory engagement covering all continents: (1) a global code of conduct for funders, (2) a fair research contracting on-line tool and (3) a compliance and ethics follow-up tool, which takes limited resources into account. Thirteen European and international partners are involved in the TRUST project, including SIGNOSIS. It will be coordinated at the Centre for Professional Ethics of the University of Central Lancashire (UK), by Prof. Doris Schroeder and in addition to SIGNOSIS the consortium consists of the Council on Health Research for Development Association (Switzerland), the Forum for Ethics Review Committees in India (India), the UN Educational, Scientific and Cultural Organization (UNESCO), the South African San Institute (South Africa), the “Institut national de la santé et de la recherche médicale”, (France), the Partners for Health and Development in Africa (Kenya), the “Action Contre La Faim” (France), the University of Witwatersrand Johannesburg (South Africa), the University of Cape Town (South Africa), the Global Values Alliance (Switzerland) and the European and Developing Countries Clinical Trials Partnership (Τhe Netherlands).